Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

INDGN - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Technical List

Technical Rating: 3.0

Let’s unravel the technical setup for Indigenous Geneomics (INDGN) and map its current chart tone along with actionable trade levels

πŸ“‰ Trend Overview

Current Price β‚Ή549 is trading below both 50-DMA (β‚Ή572) and 200-DMA (β‚Ή584) β†’ indicative of short-term and medium-term weakness.

From its high of β‚Ή737, the stock has dropped nearly 25%, hinting at a gradual downtrend phase, but holding above its recent low of β‚Ή485.

🧭 Trend Status: Trending downward with signs of base formation, fueled by solid FII interest and moderate earnings growth.

πŸ” Momentum Indicators

RSI (38.4): Approaching oversold zone β†’ potential for a short-term bounce but lacks confirmation.

MACD (-7.03): Deep negative territory β†’ underlines bearish momentum still intact.

Volume (2.88L) vs Avg Vol (3.76L): Weak turnover β†’ traders showing caution, a sign of consolidation efforts.

πŸ“Š Bollinger Bands

Likely trading near the lower band, amplifying oversold signals.

No notable band contraction; expect volatility to stay subdued unless volume picks up sharply.

πŸ“ Support & Resistance Matrix

Zone Type Price Range (β‚Ή) Commentary

Support 535 – 550 Current base zone with RSI and MACD convergence hints

Resistance 570 – 584 DMA resistance stack – key turning zone

Breakout Zone 590+ Break above moving averages β†’ trend flip confirmation

🎯 Trade Strategy

Entry Zone: β‚Ή540–₹550 (support play + oversold bounce setup)

Exit Zone: β‚Ή570–₹584 (potential rejection zone from DMAs)

Stop Loss: β‚Ή530 (below current support and recent pivot lows)

πŸ” Conclusion

INDGN is consolidating within a weak downtrend, supported marginally by improving fundamentals and institutional interest.

Watch for a volume-driven MACD flattening or RSI divergence to signal a more reliable reversal.

A decisive break above β‚Ή590 could unlock fresh upside toward β‚Ή610–₹630.

Want to pair this setup against mid-cap pharma players or biotech stocks for relative momentum analysis? I can line up a chart comparison to see who’s showing early breakout potential πŸ§ͺπŸ“Š

Edit in a page

Back to Technical List